The effect of hydralazine on blood flow and misonidazole toxicity in human tumour xenografts
- 28 February 1991
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 20 (2) , 117-123
- https://doi.org/10.1016/0167-8140(91)90145-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine : effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069Radiotherapy and Oncology, 1989
- Keynote address: Chemical manipulations of tissue oxygenation for therapeutic benefitInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Hydralazine-Induced Tumor Hypoxia: A Potential Target for Cancer ChemotherapyJNCI Journal of the National Cancer Institute, 1989
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT)British Journal of Cancer, 1986
- Oxygen tension in human tumors: in vivo mapping using CT-guided probes.Radiology, 1985
- The Effect of Oxygen Breathing and Radiotherapy upon the Tissue Oxygen Tension of some Human TumoursThe British Journal of Radiology, 1963
- Changes of Oxygen Tension in Tumours Induced by Vasoconstrictor and Vasodilator DrugsActa Radiologica, 1962
- Quantitative measurements of oxygen tension in normal tissues and in the tumours of patients before and after radiotherapyActa Radiologica, 1960